Currently, Ultralife Corp [ULBI] is trading at $8.11, down -2.29%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ULBI shares have gain 8.86% over the last week, with a monthly amount glided 44.56%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ultralife Corp [NASDAQ: ULBI] stock has seen the most recent analyst activity on March 26, 2021, when The Benchmark Company initiated its Buy rating and assigned the stock a price target of $12. Previously, Ardour Capital downgraded its rating to Reduce on May 02, 2013. On November 04, 2011, downgrade downgraded it’s rating to Hold and revised its price target to $4.50 on the stock. Ardour Capital reiterated its Hold rating and decreased its price target to $4 on May 06, 2011. Ardour Capital reiterated its recommendation of a Accumulate and raised its price target to $6.25 on October 29, 2010. Ardour Capital reiterated a Buy rating for this stock on May 14, 2010, and upped its price target to $6.50. In a note dated January 08, 2010, Merriman initiated an Neutral rating.
This stock has fluctuated between a low of $4.07 and a high of $12.40 over the last 52 weeks. Ultralife Corp [NASDAQ: ULBI] shares were valued at $8.11 at the most recent close of the market.
Analyzing the ULBI fundamentals
Trailing Twelve Months sales for Ultralife Corp [NASDAQ:ULBI] were 173.28M which represents 21.03% growth. Gross Profit Margin for this corporation currently stands at 0.25% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.04 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.96 points at the first support level, and at 7.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.32, and for the 2nd resistance point, it is at 8.52.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Ultralife Corp [NASDAQ:ULBI] is 3.22. In addition, the Quick Ratio stands at 1.70 and the Cash Ratio stands at 0.28. Considering the valuation of this stock, the price to sales ratio is 0.78, the price to book ratio is 0.99 and price to earnings (TTM) ratio is 25.74.
Transactions by insiders
Recent insider trading involved WHITMORE BRADFORD T, Director, that happened on Jun 13 ’25 when 10000.0 shares were purchased. Director, Goddard Janie completed a deal on Jun 13 ’25 to buy 1548.0 shares. Meanwhile, Director WHITMORE BRADFORD T bought 11980.0 shares on May 23 ’25.
